1. Stødle IH, Verket A, Høvik H, Sen A, Koldsland OC. Prevalence of periodontitis based on the 2017 classification in a Norwegian population: The HUNT study. J Clin Periodontol. 2021;48:1189-99.

https://doi.org/10.1111/jcpe.13507

PMid:34101228 

2. Chen MX, Zhong YJ, Dong QQ, Wong HM, Wen YF. Global, regional, and national burden of severe periodontitis, 1990-2019: An analysis of the Global Burden of Disease Study 2019. J Clin Periodontol. 2021;48:1165-88.

https://doi.org/10.1111/jcpe.13506

PMid:34101223 

3. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions: Classification and case definitions for periodontitis. J Periodontol. 2018;89:S173-82.

https://doi.org/10.1002/JPER.17-0721

PMid:29926951 

4. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55:21-31.

https://doi.org/10.1007/s00125-011-2342-y

PMid:22057194 PMCid:PMC3228943

5. Ali J, Pramod K, Tahir MA, Ansari SH. Autoimmune responses in periodontal diseases. Autoimmun Rev. 2011;10:426-31.

https://doi.org/10.1016/j.autrev.2010.04.005

PMid:21256252 

6. Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DTW. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013;26:781-91.

https://doi.org/10.1128/CMR.00021-13

PMid:24092855 PMCid:PMC3811231

7. Young JA, Schneyer CA. Composition of saliva in mammalia. Aust J Exp Biol Med Sci. 1981;59:1-53.

https://doi.org/10.1038/icb.1981.1

PMid:6165346 

8. Srinivasan M, Blackburn C, Mohamed M, Sivagami AV, Blum J. Literature-based discovery of salivary biomarkers for type 2 diabetes mellitus. Biomark Insights. 2015;10:39-45.

https://doi.org/10.4137/BMI.S22177

PMid:26005324 PMCid:PMC4433061

9. Rathnayake N, Akerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, et al. Salivary biomarkers for detection of systemic diseases. PLoS One. 2013;8:e61356.

https://doi.org/10.1371/journal.pone.0061356

PMid:23637817 PMCid:PMC3634781

10. Al-Rawi NH, Al-Marzooq F, Al-Nuaimi AS, Hachim MY, Hamoudi R. Salivary microRNA 155, 146a/b and 203: A pilot study for potentially non-invasive diagnostic biomarkers of periodontitis and diabetes mellitus. PLoS One. 2020;15:e0237004.

https://doi.org/10.1371/journal.pone.0237004

PMid:32756589 PMCid:PMC7406085

11. Arya S, Kaji AH, Boermeester MA. PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg. 2021;156:789-90.

https://doi.org/10.1001/jamasurg.2021.0546

PMid:33825806 

12. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.

https://doi.org/10.1186/1471-2288-5-13

PMid:15840177 PMCid:PMC1097734

13. Reher VGS, Zenóbio EG, Costa FO, Reher P, Soares RV. Nitric oxide levels in saliva increase with severity of chronic periodontitis. J Oral Sci. 2007;49:271-6.

https://doi.org/10.2334/josnusd.49.271

PMid:18195509 

14. Sundar NM, Krishnan V, Krishnaraj S, Hemalatha VT, Alam MN. Comparison of the salivary and the serum nitric oxide levels in chronic and aggressive periodontitis: a biochemical study. J Clin Diagn Res. 2013;7:1223-7.

https://doi.org/10.7860/JCDR/2013/5386.3068

PMid:23905146 PMCid:PMC3708241

15. Rangbulla V, Nirola A, Gupta M, Batra P, Gupta M. Salivary IgA, Interleukin-1β and MMP-8 as salivary biomarkers in chronic periodontitis patients. Chin J Dent Res. 2017;20:43-51.

PMid:28232966

16. Nikita BG, Hosmani JV, Bhat KG, Kotrashetti VS, Nayak RS, Babji DV, et al. Detection of antibodies against Aggregatibacter actinomycetemcomitans in serum and saliva through ELISA in periodontally healthy individuals and individuals with chronic periodontitis. Microb Pathog. 2018;125:438-42.

https://doi.org/10.1016/j.micpath.2018.10.007

PMid:30312650 

17. Ebersole JL, Schuster JL, Stevens J, Dawson D 3rd, Kryscio RJ, Lin Y, et al. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol. 2013;33:271-9.

https://doi.org/10.1007/s10875-012-9771-3

PMid:22926406 PMCid:PMC3788639

18. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc. 2006;137:322-9.

https://doi.org/10.14219/jada.archive.2006.0181

PMid:16570465 

19. Christoph RA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol. 2009;80:436-46.

https://doi.org/10.1902/jop.2009.080480

PMid:19254128 PMCid:PMC5695217

20. Teles RP, Likhari V, Socransky SS, Haffajee AD. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res. 2009;44:411-7.

https://doi.org/10.1111/j.1600-0765.2008.01119.x

PMid:19210336 PMCid:PMC2712869

21. Glimvall P, Wickström C, Jansson H. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?: Salivary lactoferrin and chronic periodontitis. J Periodontal Res. 2012;47:655-60.

https://doi.org/10.1111/j.1600-0765.2012.01479.x

PMid:22471324 

22. Cardoso EM, Reis C, Manzanares-Céspedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med. 2018;130:98-104.

https://doi.org/10.1080/00325481.2018.1396876

PMid:29065749 

23. Uciechowski P, Dempke WCM. Interleukin-6: A masterplayer in the cytokine network. Oncology. 2020;98:131-7.

https://doi.org/10.1159/000505099

PMid:31958792 

24. Isola G, Lo Giudice A, Polizzi A, Alibrandi A, Murabito P, Indelicato F. Identification of the different salivary Interleukin-6 profiles in patients with periodontitis: A cross-sectional study. Arch Oral Biol. 2021;122:104997.

https://doi.org/10.1016/j.archoralbio.2020.104997

PMid:33291049 

25. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol. 1987;138:1464-8.

https://doi.org/10.4049/jimmunol.138.5.1464

PMid:3492553 

26. Sato M, Nakajima T, Goto M, Umezawa Y. Cell-based indicator to visualize picomolar dynamics of nitric oxide release from living cells. Anal Chem. 2006;78:8175-82.

https://doi.org/10.1021/ac061791b

PMid:17165805 

27. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9:S1.

https://doi.org/10.1186/ar2165

PMid:17634140 PMCid:PMC1924516

28. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol. 2006;208:270-82.

https://doi.org/10.1002/path.1877

PMid:16362985 

29. Sodek J, Overall CM. Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl. 1992;1:352-62.

PMid:1480060

30. Paul WE. History of interleukin-4. Cytokine. 2015;75:3-7.

https://doi.org/10.1016/j.cyto.2015.01.038

PMid:25814340 PMCid:PMC4532601

31. Pradeep AR, Roopa Y, Swati PP. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res. 2008;43:712-6.

https://doi.org/10.1111/j.1600-0765.2007.01079.x

PMid:18624944 

32. Passoja A, Puijola I, Knuuttila M, Niemelä O, Karttunen R, Raunio T, et al. Serum levels of interleukin-10 and tumour necrosis factor-α in chronic periodontitis: Systemic inflammatory responses in chronic periodontitis. J Clin Periodontol. 2010;37:881-7.

https://doi.org/10.1111/j.1600-051X.2010.01602.x

PMid:20718895 

33. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993;362:248-50.

https://doi.org/10.1038/362248a0

PMid:8096327 

34. Hönig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Increased interleukin-1 beta (IL-1 beta) concentration in gingival tissue from periodontitis patients. J Periodontal Res. 1989;24:362-7.

https://doi.org/10.1111/j.1600-0765.1989.tb00883.x

PMid:2531790 

35. Chaturvedi M, Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol. 2014;49:563-73.

https://doi.org/10.1007/s12035-013-8538-z

PMid:24026771 PMCid:PMC3918117

36. Kim HD, Kim S, Jeon S, Kim SJ, Cho HJ, Choi YN. Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis. J Clin Periodontol. 2020;47:1191-200.

https://doi.org/10.1111/jcpe.13349

PMid:32744384 

37. Stríz I, Trebichavský I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245-53.

https://doi.org/10.33549/physiolres.930448

PMid:15209531 

38. Nishikawa Y, Kajiura Y, Lew JH, Kido JI, Nagata T, Naruishi K. Calprotectin induces IL-6 and MCP-1 production via toll-like receptor 4 signaling in human gingival fibroblasts: Calprotectin/tlr4 induced-cytokine production. J Cell Physiol. 2017;232:1862-71.

https://doi.org/10.1002/jcp.25724

PMid:27925202 

39. Palys MD, Haffajee AD, Socransky SS, Giannobile WV. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J Clin Periodontol. 1998;25:865-71.

https://doi.org/10.1111/j.1600-051X.1998.tb02383.x

PMid:9846794 PMCid:PMC2653097

40. Gursoy UK, Könönen E, Pradhan-Palikhe P, Tervahartiala T, Pussinen PJ, Suominen-Taipale L, et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis: MMP-8 in periodontitis. J Clin Periodontol. 2010;37:487-93.

https://doi.org/10.1111/j.1600-051X.2010.01563.x

PMid:20507371